Physical exercise on inflammatory markers in type 2 diabetes patients: a systematic review of randomized controlled trials by Melo, L.C. et al.
Review Article
Physical Exercise on Inflammatory Markers in Type 2 Diabetes
Patients: A Systematic Review of Randomized Controlled Trials
Luciana Costa Melo,1,2,3 Jaime Dativo-Medeiros,1,2,3 Carlos EduardoMenezes-Silva,1,2,3
Fabiano Timbó Barbosa,1 Célio Fernando de Sousa-Rodrigues,1 and Luiza A. Rabelo1,2,3,4
1Programa de Po´s-Graduac¸a˜o em Cieˆncias da Sau´de, Instituto de Cieˆncias Biolo´gicas e da Sau´de, Universidade Federal de Alagoas,
Campus A. C. Simo˜es, Av. Lourival Melo Mota, s/n, Tabuleiro do Martins, 57072-900 Maceio´, AL, Brazil
2Laborato´rio de Reatividade Cardiovascular, Setor de Fisiologia, Nu´cleo de Sı´ndrome Metabo´lica,
Instituto de Cieˆncias Biolo´gicas e da Sau´de, Universidade Federal de Alagoas, Maceio´, AL, Brazil
3Instituto Nacional de Cieˆncia e Tecnologia em Nanobiofarmaceˆutica (N-BIOFAR), Belo Horizonte, MG, Brazil
4Max Delbru¨ck Center for Molecular Medicine, Berlin, Germany
Correspondence should be addressed to Fabiano Timbo´ Barbosa; fabianotimbo@yahoo.com.br
and Luiza A. Rabelo; luizaa.rabelo@gmail.com
Received 15 October 2016; Revised 7 December 2016; Accepted 23 February 2017; Published 19 March 2017
Academic Editor: Sara Baldelli
Copyright © 2017 Luciana Costa Melo et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Background. Type 2 diabetes mellitus (T2DM) is a serious disease associated with high morbidity and mortality. Scientific findings
showed that physical exercise is an option for treatment of these patients. This study’s objective is to investigate the effects of
supervised aerobic and/or resistance physical training on inflammatory markers in subjects with T2DM. Methods. A systematic
review was conducted on four databases, MEDLINE, CENTRAL, LILACS, and Scopus, andmanual search from 21 to 30 November
2016. Randomized clinical trials involving individuals diagnosed with T2DM, who have undergone supervised training protocols,
were selected in this study. Results. Eleven studies were included. Studies that evaluated control group versus aerobic exercise
reported controversial results about the effectiveness of physical training in modifying C-reactive protein (CRP) and cytokine
levels. The only variable analyzed by the six studies in comparison to the control group versus resistance exercise was CRP. This
protein showed no significant difference between groups. Between the two modes of exercise (aerobic and resistance), only one
study demonstrated that aerobic exercise was more effective in reducing CRP. Conclusion. The evidence was insufficient to prove
that aerobic or resistance exercise improves systemic levels of inflammatory markers in patients with T2DM.
1. Introduction
The term diabetes mellitus (DM) describes a metabolic dis-
order of multiple etiologies characterized by chronic hyper-
glycemia, with carbohydrate, fat, and protein metabolism
disorders resulting from defects in insulin secretion or action
[1].
According to statistics, a DM epidemic is underway [2].
In 1985, an estimated 30 million adults around the world had
diabetes; by 1995, this number had increased to 135 million,
reaching 347 million in 2013, and diabetes is predicted to be
the 7th leading cause of death by the year 2030 [3]. In this
scenario, type 2 diabetes (T2DM) is the form present in 90%
to 95% of cases [3].
Hyperglycemia, the main signal of DM, is even one
component of the metabolic syndrome (SMet) which can be
defined as the coexistence of metabolic disorders (abdominal
obesity, hypertriglyceridemia, low HDL cholesterol, high
blood pressure, or high fasting glucose) [4]. Although the
metabolic pathways linking these disturbances are not com-
pletely clear, a proinflammatory state has been found to be an
important element in the pathophysiology of the syndrome
or T2DM [5, 6].
Obesity, especially visceral, is one of the most important
factors in the development of diabetes through various
mechanisms, such as increased circulating free fatty acids,
adiponectin decrease, and secretion of cytokines in the
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adipose tissue, such as tumor necrosis factor-alpha (TNF-𝛼)
and interleukin-6.The proinflammatorymolecules produced
in the adipose tissue can activate pathways that result in
disruption of systemic insulin sensitivity and glucose home-
ostasis that are characteristic of T2DM [5].
In addition to the participation of inflammatory pro-
cesses in the pathogenesis of diabetes, evidence has shown
that hyperglycemia itself contributes to the generation of
proinflammatory factors. Hyperglycemia promotes the pro-
duction of interleukin-1𝛽 (IL-1𝛽) by pancreatic 𝛽-cells. IL-
1𝛽 induces the production of various types of cytokines
and chemokines through activation of the nuclear factor-
𝜅B, which triggers the recruitment of macrophages [7]. In
fact, cross-sectional and prospective studies have described
elevated levels of C-reactive protein (CRP) [8], cytokines [8–
10], and chemokines [8–10] in patients with T2DM.
With regard to diabetes treatment, physical exercise
stands out as an important ally for glycemic control and
other comorbid factors, such as hypertension and dys-
lipidemia, and for reducing cardiovascular risk [11, 12]. It
is well established in the literature that physical exercise
improves insulin sensitivity [13], increasing glucose uptake
in muscles and adipocytes and reducing blood glucose levels
[14]. Moreover, exercise increases blood glucose uptake by
the muscles through insulin-independent mechanisms that
involve GLUT4 activation by muscle contraction [15]. Thus,
physical exercise facilitates glucose metabolism and its effi-
ciency, improving glycemic control, which can be observed
by the lower basal and postprandial insulin concentrations
and the reduction of glycated hemoglobin in physically active
diabetics when compared to sedentary patients [16, 17]. It is
important to consider that the normalization of blood glucose
is not sufficient to remove clinical outcomes in type 2 diabetes
[17].Despite the above-described scenario, to date, no reviews
have demonstrated the effects of physical exercise on the
inflammation characteristic of diabetes. Therefore, this study
aims to investigate the effects of supervised aerobic and/or
resistance physical training on inflammatory markers in
T2DMpatients.We ask for scientific evidence on randomized
controlled trials in which patients with T2DM performed
supervised exercise training protocols.
2. Methods
Aprotocol was drawnup in preparation for this review,which
is available upon request to the corresponding author should
there be a need for analysis. The study is reported according
to the guidelines of the “Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses” (PRISMA Statement;
Supplementary Data available at https://doi.org/10.1155/2017/
8523728) [18]. The results were not influenced by the source
of the studies (authors or institutions where they were carried
out). This systematic review was not registered with the
International Prospective Register of Systematic Reviews
(PROSPERO).
The search strategy aimed to identify randomized con-
trolled trials (RCTs) that used physical exercise as a treatment
strategy for patients with T2DM.
2.1. Databases. The studies were identified in four electronic
databases: MEDLINE (via PubMed, from 2006 to November
2016), Cochrane Central Register of Controlled Trials (CEN-
TRAL, Issues 3, 2016), Scopus (from 2006 toNovember 2016),
andLILACS (via BIREME interface, 2006 toNovember 2016).
The search procedure was carried out from 21 January to 26
November 2016.
The strategy used here considered the terms of most
interest to the review: “Diabetes Mellitus,” “Exercise” and
“Randomized controlled trial.” A combination of three terms
were used in PubMed, Scopus, and LILACS: “Diabetes Mel-
litus” AND “Exercise” AND “Randomized controlled trial”,
while a combination of two terms were used in CENTRAL:
“Diabetes Mellitus” AND “Exercise”. In addition, searches
were made in the reference lists of the selected articles for
inclusion in this review. Text filters, availability, and/or origin
of the study were not used.We used filters to publication date
(articles published in the last 10 years) and age (studies with
subjects aged 18 years or older).
2.2. Selection of Studies. RCTs were selected in which the
participants were 18 years old or older, who had been defini-
tively diagnosed with T2DM. The diagnosis was considered
based on information contained in the article, regardless of
the criteria used, without gender restriction.
The search focused on trials that used aerobic and/or
resistance exercise in programs supervised by professionals.
Trials in which the exercise program was associated with
dietary or prescription medications to control T2DM were
excluded. This could be a source of bias because the effects
on the analyzed variables could be from these associated
treatments.
We considered the control group as subjects that did
not do supervised exercise program, maintained their daily
routine activities, or were asked to perform less than 150
minutes of low grade exercise per week. We considered
placebo training when subjects performed the same kind of
exercise of trained groups but without load.
Trials composed of two groups performing different
kinds of exercise (aerobic and resistance) were considered
to compare the most effective exercise on modifying inflam-
matory biomarkers. On the other hand, studies comparing
two groups of the same exercise on different intensities were
not considered, because there are a large variety of intensities
what could be a source of bias in the analysis.
Based on this selection, three possibilities were con-
sidered for analysis between groups: (i) aerobic exercise
versus control, (ii) resistance exercise versus control, and (iii)
aerobic exercise versus resistance exercise.
The first variable of interest was the plasma CRP level,
because it is an inflammatory marker provenly altered in
patients with T2DM [7]. Plasma cytokines associated with
inflammation (adiponectin, tumor necrosis factor-𝛼, inter-
leukins, and/or other cytokines with specific activity) were
considered secondary variables.
The articles were identified by three authors indepen-
dently, based on the titles and abstracts. Disagreements about
their eligibility were resolved in a consensus meeting, after
which the full texts of the selected articles were downloaded.
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Figure 1: Workflow of information through the different phases of the systematic review.
The articles were then evaluated again independently by three
authors of this review. The RCTs included in this review
were defined by consensus. Figure 1 summarizes the search
methodology.
2.3. Extraction of Data. Preformatted forms were filled out
containing identifying information about the study, charac-
teristics of the sample, and data on the variables of interest.
Data not available in the article were requested by email from
the authors.
The data extraction procedure was performed by three
authors independently. Each author read the included article
and plotted the data of interest on tables previously designed.
After this, the tables were compared to confirm accuracy of
the extraction. Any disagreements about how to complete the
forms were resolved in a consensus meeting.
Data from included studies were described as measures
of central tendency and dispersion. Analysis was performed
according to possible comparisons: (i) aerobic exercise versus
control, (ii) resistance exercise versus control, and (iii) aero-
bic exercise versus resistance exercise.
2.4. Ethical Approval. This is a literature review-based study
that did not involve experiments with animals or humans. No
specific ethical approval is required for this kind of study and
informed consent for participation is not applicable.
3. Results
3.1. Selection of Studies. The studies to be included in this
review were identified during the period of 21 January 2016
to 26 November 2016. The search strategy resulted in the
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Table 1: Treatments compared in the included studies.
Control group versus aerobic training Control group versus resistance training Aerobic training versus resistance training
Kadoglou et al., 2007 [26]
Oberbach et al., 2008 [21]
Jorge et al., 2011 [22]
Swift et al., 2012 [28]
Kadoglou et al., 2012 [23]
Kadoglou et al., 2013 [29]
Moghadasi et al., 2013 [30]
Brooks et al., 2007 [20]
Jorge et al., 2011 [22]
Swift et al., 2012 [28]
Kadoglou et al., 2012 [27]
Kadoglou et al., 2013 [29]
Mavros et al., 2014 [25]
Jorge et al., 2011 [22]
Sukala et al., 2012 [24]
Swift et al., 2012 [28]
Kadoglou et al., 2013 [29]
identification of 1,051 articles in the four aforementioned
databases. After discarding duplicates, 625 articles were
considered for the analysis of titles and abstracts. Among
these, however, only 39 met the eligibility criteria and their
full texts were analyzed. After analyzing the methodologies
used in the randomized clinical trials, another 28 articleswere
excluded. Among these, six involved treatments associating
physical exercise with dietary prescriptions, four involved
unsupervised exercise programs, three compared two aerobic
exercise programs at different levels of intensity but did not
include a control group, one applied a protocol of aerobic
exercise combined with resistance exercise, and fourteen
did not evaluate CRP and/or inflammatory cytokine plasma
levels. In the end, eleven studies met the preestablished
eligibility criteria and were therefore included in this review.
Amanual search of the references listed in these seven articles
was performed, but no studies were found that met the
eligibility criteria besides the ones already selected (Figure 1).
3.2. Characteristics of Included Studies. The eleven studies
selected to be included in this review were randomized
controlled trials published in English, which used aerobic or
resistance exercise for the treatment of patients above 18 years
of age diagnosedwith T2DM.Among these studies, four were
conducted in Greece, two in the United States, one in New
Zealand, one in Brazil, one in Australia, one in Iran, and one
in Germany.
Among these eleven studies, ten used control groups. Two
of these control groups received placebo training, three were
instructed to perform 150 minutes per week of low-intensity
physical activities, one was offered low-intensity stretching
exercises once a week, and two were told to keep up their
routine daily activities. Two studies did not describe the
characteristics of their control groups.
Eight studies used aerobic training, while seven studies
used resistance training. Considering themethods employed,
it was possible to compare control group versus aerobic
training, control group versus resistance training, and aerobic
training versus resistance training in seven, six, and four
studies, respectively (Table 1). Table 2 describes the training
programs and training intensities employed in these studies.
The seven studies included in this review involved 633
participants, all diagnosed with T2DM, who did not engage
in regular physical activity. The plasma CRP levels were
analyzed in ten studies (582 participants) before and after the
full course of treatment.
Seven studies evaluated different inflammation-associ-
ated cytokines (Table 2): vaspin, human apelin-12, visfatin,
ghrelin, adiponectin, resistin, tumor necrosis factor-𝛼 (TNF-
𝛼), interleukin-6 (IL-6), IL-10, and IL-18. All included studies
were considered on descriptive analysis and discussion of the
results.
3.3. Meta-Analysis. The design of this systematic review
included a meta-analysis of plasma CRP and cytokine levels.
However, upon reviewing the studies, it was impossible to
perform this statistical procedure for the following reasons
[19]:
(1) Seven studies presented pre- and posttreatment ana-
lytical data [20–25], while four reported pre- and
posttreatment delta variations [26–29] and three
studies presented some results in a graph form,
without providing data that would enable this analysis
[23, 24, 26].
(2) Eight studies presented their data as mean values ±
standard deviations [22–27, 29, 30], one as mean ±
standard error of the mean [21], another as median
± standard deviation [20], and one as mean and
confidence interval [28].
(3) The CRP data were expressed in different units of
measure (mmol/l, mg/l, mg/l, pg/ml, and log).
(4) The studies measured plasma levels of different
cytokines. When more than one study analyzed the
same cytokine, the above-described problems pre-
cluded the implementation of the meta-analysis.
The authors were asked via email to provide data required
to perform the meta-analysis, but only one group [24]
answered and sent the requested data.
After attempting to combine the studies to proceed with
the meta-analysis, only two studies in each exercise modality
were eligible for statistical analysis.This kind of analysis could
not be able to translate the effect of interventions and was
disconsidered.
3.4. Assessment of Heterogeneity. The sample of ten studies
was composed of individuals of both sexes, albeit with a
predominance of women. Moghadasi et al.’s (2013) [30] study
had a sample composed of just men. The average age of the
participants showed a little variation between the RCTs, with
averages ranging from 48 to 68 years of age. On the other
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Table 2: Description of training programs employed in the treatment of participants in randomized clinical trials.
Author,
year Country Participants
Interventions,
group (𝑛)
Intervention
period
Inflammatory
status variables
analyzed
Results Remarks
Brooks et
al., 2007
[20]
United
States
Hispanic man
and woman, 55
years old and
older with
diagnosed
T2DM
Control (31):
recommended to
continue usual
standard of care.
Resistance (31):
60–80% of 1RM
during the first 9
weeks and 70–80%
of 1RM on weeks
10–16.
45min/session,
3x/week,
for 4 months
CRP (mg/l)
Adiponectin
(𝜇g/ml)
Reduction in serum
CRP level in
resistance training
group compared with
control group.
Increase in
adiponectin
concentrations in
resistance group
compared with
control group.
Data from CRP
and adiponectin
were exposed as
median and
interquartile range.
Kadoglou
et al., 2007
[26]
Greece
Man and
woman
with diagnosed
T2DM
Control (30): no
programmed
activity.
Aerobic (30):
50–75% of
maximum O2
consumption.
60min/session,
4x/week,
for 6 months
hsCRP (mg/dl)
Adiponectin
(𝜇g/ml)
TNF-𝛼 (pg/ml)
Interleukin-18
(pg/ml)
Interleukin-10
(pg/ml)
Reduction in hsCRP
and interleukin-18
after aerobic training
compared with
control group.
Increase in
interleukin-10 after
aerobic training
compared with
control group.
Nonsignificant
changes in TNF-𝛼 or
adiponectin in either
group or between the
groups after the
intervention.
Data from hsCRP,
adiponectin,
TNF-𝛼,
interleukin-10, and
interleukin-18 were
exposed on graphs
without values of
mean and standard
deviation.
Oberbach
et al., 2008
[21]
Germany
Man and
woman
with glucose
impaired
tolerance
Control (16): not
described.
Aerobic (24): load
not described.
60min/session,
2x/week,
for 12 months
hsCRP (pg/ml)
Interleukin-6
(pg/ml)
Reduction in hsCRP
and interleukin-6
serum level in the
aerobic group after
intervention.
Data before and
after intervention
exposed on
analytical values
(mean ± standard
error of mean).
Jorge et al.,
2011 [22] Brazil
Man and
woman
aged 30–70
years
diagnosed with
T2DM and with
body mass index
between 25 and
40 kg/m2
Control (12): light
stretching exercise.
Aerobic (12): up to
lactate threshold.
Resistance (12):
load not described.
Combination (12):
aerobic and
resistance training
with the same
intensity of the
other training
groups and half of
the exercise
volume on each
category.
60min/session,
3x/week,
for 3 months
hsCRP (mg/ml)
Adiponectin
(𝜇g/ml)
Visfatin (ng/ml)
Resistin (ng/ml)
TNF-𝛼 (pg/ml)
Interleukin -6
(pg/ml)
Reduction in hsCRP
serum level in all
groups, including
control after
intervention.
Increase in visfatin
serum level in all
groups, including
control after
intervention.
Nonsignificant
changes in
adiponectin, resistin,
TNF-𝛼, or
interleukin-6 in either
group after
intervention.
Data before and
after intervention
exposed on
analytical values
(mean ± standard
deviation).
Kadoglou
et al., 2012
[23]
Greece
Man and
woman
aged 50–70
years
with a diagnosis
of T2DM
Control (27): 150
minutes/week of
self-managed
physical activity.
Aerobic (26):
progressive load
until 60%–75% of
HRmax.
60min/session,
4x/week,
for 3 months
Human
apelin-12
(ng/ml)
Ghrelin (ng/ml)
Increment on apelin
serum level after the
intervention period
on aerobic training
group compared with
control group.
Nonsignificant effect
on ghrelin serum
level in the
intervention group.
Data from apelin
and ghrelin were
exposed on graphs
without values of
mean and standard
deviation.
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Table 2: Continued.
Author,
year Country Participants
Interventions,
group (𝑛)
Intervention
period
Inflammatory
status variables
analyzed
Results Remarks
Kadoglou
et al., 2012
[27]
Greece
Man and
woman with
T2DM
diagnosed for
more than 1 year
Control (24): 150
minutes/week of
self-managed
physical activity.
Resistance (23): 2-3
sets of 6–8
repetitions on
machine weights.
Exercise intensity
of 60–80% of 1RM.
60min/session,
3x/week,
for 3 months
hsCRP (mg/l)
Nonsignificant
changes in CRP levels
between the groups
after the intervention.
Data expressed as
delta variation
(mean ± standard
deviation).
Sukala et
al., 2012
[24]
New
Zealand
Man and
woman
self-identified
Polynesian
descent, with
clinical
diagnosis of
T2DM and
visceral obesity
Aerobic (9):
65–80% of heart
rate reserve
(HRreserve).
Resistance (9):
progressive load
(5%) starting from
the execution of 10
repetitions.
40 to
60min/session,
3x/week,
for 4 months
CRP (log)
Adiponectin
(𝜇g/ml)
Nonsignificant
changes in CRP or
adiponectin in either
group or between the
groups after the
intervention.
Data expressed as
delta variation
(mean ± standard
deviation).
Swift et al.,
2012 [28]
United
States
Man and
woman aged
35–70 years
with diagnosed
T2DM
Control (37):
weekly stretching
and relaxation.
Aerobic (50):
50–80% of
maximum O2
consumption.
Resistance (58):
progressive load
starting from the
execution of 12
repetitions.
Combination (59):
combination of
aerobic training
(10 kcal/kg/week)
plus 2 sessions of
resistance training
per week.
150min/week,
3x/week,
for 9 months
CRP (mg/l)
Nonsignificant
change in CRP serum
level in either group
or between the groups
after the intervention.
Data expressed as
delta variation
(mean ±
confidence
interval).
Kadoglou
et al., 2013
[29]
Greece
Man and
woman with
T2DM
diagnosed
for more than 1
year.
Control (24): 150
minutes/week of
self-managed
physical activity.
Aerobic (21):
progressive load
until 60%–75% of
HRmax.
Resistance (23):
load of 60%–80%
of 1-MR.
Combination (22):
aerobic and
resistance training
with the same
intensity of the
other training
groups and half of
the exercise
volume on each
category.
60min/session,
4x/week,
for 6 months
hsCRP (mmol/l)
Vaspin (ng/ml)
Human
apelin-12
(ng/ml)
Visfatin (ng/ml)
Ghrelin (ng/ml)
Reduction in hsCRP
and visfatin serum
level after aerobic and
combined training
compared with both
resistance training
alone and control
groups.
Increment on apelin
and vaspin serum
level in the aerobic
exercise and
combined groups
rather than in the
control and resistance
training groups.
Nonsignificant effect
on ghrelin serum
level in the
intervention groups.
Data from vaspin,
apelin, visfatin, and
ghrelin were
exposed on graphs
without values of
mean and standard
deviation.
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Author,
year Country Participants
Interventions,
group (𝑛)
Intervention
period
Inflammatory
status variables
analyzed
Results Remarks
Moghadasi
et al., 2013
[30]
Iran
Obese and
overweight man
with T2DM
Control (8): not
described.
Aerobic (8):
40–59% of
maximum O2
consumption.
30min/session,
4x/week,
for 3 months
hsCRP (mg/ml)
Adiponectin
(𝜇g/l)
Nonsignificant
changes
in CRP in either
group or between the
groups after the
intervention.
Adiponectin level
increased in training
group compared with
pretraining values.
—
Mavros et
al., 2014
[25]
Australia
Man and
woman ≥60
years of age,
sedentary with
type 2 diabetes
and metabolic
syndrome
Control (47):
training on the
same equipment
used by resistance
group, 3 times a
week, under
supervision from
the same trainers.
Exercise intensity
as low as possible
and not
progressing.
Resistance (41): 3
sets of 8
repetitions.
Exercise intensity
of 80% of 1RM.
Session duration
not informed,
3x/week, for 12
months
CRP (mg/l)
Reduction in CRP in
resistance group
relative to control
group.
—
hand, the training programs varied significantly (Table 2).
The duration of the exercise sessions was similar in seven
studies (60 minutes). However, the frequency of training
varied from 2 to 4 times per week. One of the studies did
not report the duration and frequency of sessions, only the
total workout time per week. Moreover, follow-up of the
participants varied from three to twelve months.
The load applied in aerobic training sessions was defined
based on different parameters: maximum heart rate, heart
rate reserve, maximal oxygen uptake, and lactate threshold.
Two studies did not report this load.
The intensity of resistance exercise was also variable:
four studies used 60–80% of one maximum repetition, while
two other studies considered the performance of a number
of repetitions (10 or 12 repetitions) as the parameter of
evaluation. One study did not describe the load applied in
resistance training.
4. Discussion
The focus of this review was to investigate the effects of
physical exercise on inflammatory markers. Analyzing the
studies published until the selection procedure, we observed
that the authors of the included RCTs used different train-
ing programs in their methodologies. Variations in time,
frequency, and intensity of exercise impaired comparison
between the studies. These are parameters that directly inter-
fere in metabolic response to exercise [31–35] and compar-
isons between different treatments could be a source of bias.
These facts prevented evidence from being gathered which
would support or refute the hypothesis that physical exercise
can improve the proinflammatory state of individuals with
T2DM.
The studies that compare a group of individuals who
performed aerobic exercise with a control group [21–23, 26,
28–30] present contradictory results about the effectiveness
of training to reduce plasma CRP levels. While Kadaglou et
al. [26], Oberbach et al. [21], andKadaglou et al. [29] reported
a reduction in the plasma CRP levels of trained individuals,
three other studies found no significant difference in this
parameter [22, 28, 30] when comparing the control group
versus the aerobic group after the intervention. It was not
possible to identify a specific outcome of exercise that could
be related to different results from these studies. The aerobic
training protocols used similar time of session training
(30–60 minutes), but the divergence appears regarding dura-
tion of patient follow-up, weekly workout frequency, and
training intensity.
As for the evaluation of cytokines, the data reported
in the analyzed studies are still incipient. The two studies
that analyzed TNF-𝛼 [22, 26] found no difference between
the aerobic training group and the control group after
the exercise protocol. There were no significant changes
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in adiponectin serum level in participants of two studies
that evaluated this variable [22, 26]. On the other hand,
adiponectin levels increased in the aerobic training group
compared with pretraining values in Moghadasi et al.’s study
[30]. Twoother RCTs [23, 29] assessed ghrelin plasmatic level,
but no significant changes were found between the groups
compared.
Conflicting results were observed in the analysis of IL-
6 and visfatin. Oberbach et al. [21] concluded that aerobic
exercise reduces plasma levels of IL-6, while Jorge et al.
[22] found no significant difference for this marker. Data
of visfatin measurement demonstrated a reduction in par-
ticipants of aerobic exercise program in comparison with
controls [29]. On the other hand, Jorge et al. [22] found
an increase in visfatin serum level in all groups, including
control, after the follow-up period when compared with
baseline measurements.
Increments on human apelin-12 serum level in the aerobic
exercise group rather than in the control groups were found
in two studies [23, 29], but both from the same population.
Only one study evaluated serum level of resistin [22], vaspin
[29], IL-18 [26], and IL-10 [26].
In studies comparing individuals in resistance training
with a control group [20, 22, 25, 27–29], the only variable
of interest analyzed for all was CRP. Four studies reported
finding no significant difference between the control and
trained groups [22, 27–29] while two trials found a reduction
in CRP serum level in resistance training groups when
compared with the control group [20, 25]. Visfatin serum
level was analyzed in two studies [19, 22]; in both, there were
no significant changes after resistance exercise programwhen
compared with the control group. Brooks et al. [20] reported
reduction in adiponectin serum levels in the treated group
compared with the control group while Kadoglou et al. [27]
found no significant difference. Vaspin [29], human apelin-12
[29], ghrelin [29], resistin [22], TNF-𝛼 [22], and interleukin-
6 [22] were evaluated in just one of the six studies.Thismakes
conclusive analysis impossible. Furthermore, such findings
should be considered carefully becausewhen resistance loads,
weekly training frequency, and follow-up periods differ, there
can be no reproducibility of results.
Among the studies that compared the two types of exer-
cise (aerobic and resistance) [22, 24, 28, 29], only Kadaglou
et al. [29] demonstrated that aerobic exercise decreased the
CRP levels in comparison to those individuals undergoing
resistance training. Also, in this study, an increment in apelin
and vaspin was found after aerobic training in comparison
with the resistance group. The studies found no difference
in the levels of other cytokines (ghrelin [22, 29], adiponectin
[22, 24], TNF-𝛼 [22], resistin [22], and IL-6 [22]) between the
groups after the training protocol.
It is important to highlight that T2DM is a disease
with multifactorial etiology that affects many physiological
systems. Because of this, the treatment must contemplate
several strategies in order to promote the health of individuals
with T2DM. Data from the Italian Diabetes and Exercise
Study (IDES) [36–38] showed that aerobic or combined
(aerobic and resistance) exercise was effective in reducing
CRP plasma levels after 12 months of training in T2DM
patients receiving standard medical care (nutritional guid-
ance and pharmacological treatment). Similar results were
observed in other inflammatorymarkers. Leptin, resistin, and
interleukin-6 decreased, whereas adiponectin increased in
exercising groups [37]. Interleukin-1𝛽, tumor necrosis factor-
𝛼, and interferon-𝛾 decreased, whereas anti-inflammatory
interleukin-4 and interleukin-10 increased only in the group
that performed combined exercise [37].
On the other hand, even in studies with other treatments
associated with exercise, the results are contradictory. While
Choi et al. [39] demonstrated that CRP decreased in an
exercising group of T2DM patients after 12 weeks, no signifi-
cant differences were observed in interleukin-6. Byrkjeland
et al. [40] found no difference in CRP plasma level from
individuals in a training program or sedentary individuals.
It is interesting that changes in VO2max, exercise modal-
ities, and training supervision were strong predictors of
inflammation reduction in IDES [36–38]. In the analyzed
studies in this review, it is possible that divergences in
results are related to characteristics of applied exercise. This
reinforces the importance of individuality in the prescription
of exercise program and the supervision of training by a
professional.
In this review, two RCTs did not clearly state the intensity
of aerobic exercise [21] and the load applied in resistance
training [22]. This seriously compromises the systematic
analysis of results, since training intensity implies different
metabolic alterations [33, 34].Thus, the results of studies that
used different training modalities and/or intensities cannot
be compared.
Although this systematic review identified a sufficient
number of RCTs to perform a meta-analysis, their method-
ological heterogeneity led to a careful analysis in terms
of clinical applicability of the results, since they are from
different interventions.
The presentation of data in different units of measure or
in graph format (without numerical information on mean
and standard deviation) prevented a statistical comparison
of the results of most included studies. This showed us that
there is no standardization in the presentation format of the
biochemical data in the analyzed scientific articles, which
makes an analysis to provide subsidies to refute or confirm
the initial hypotheses of this systematic review difficult.
From the standpoint of clinical applicability, the studies
show little power to endorse the recommendation of physical
exercise as a strategy to reverse or control the inflammatory
state in diabetes. However, previously published reviews have
shown that exercise is effective for glycemic control [34, 35]
and improved arterial function [41]. Therefore, the results of
this review do not contraindicate the use of exercise in the
nonpharmacological therapeutic management of diabetes,
since there is evidence of benefits for other disorders pre-
sented by individuals with T2DM [34, 35, 41].
Limitations of this study were the presence of method-
ological heterogeneity in the studies selected for this meta-
analysis, the lack of data that could be analyzed by meta-
analysis, and the restriction of the selection to studies on
T2DM.
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5. Conclusions
The evidence was insufficient to prove that aerobic or resis-
tance training improves plasma levels of inflammatorymark-
ers in patients with T2DM. Thus, we recommend further
studies designed with the methodological rigor necessary to
prove or disprove the effectiveness of this strategy in reversing
inflammation associated with T2DM.
To date, no other reviews have been published about the
effects of physical exercise on inflammation in patients with
T2DM. Thus, the systematic review of scientific literature
on the subject in question provides supporting evidence
to underpin new studies that can meet the methodological
requirements for the establishment of scientific evidence.
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